Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance ...

After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

Researchers launch a world-first project targeting low eye pressure, offering new hope for patients at risk of vision loss ...

The first patient has been treated in Oxford in the second phase of an international clinical trial testing a new gene ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany-- 12 January, 2026 -- Boehringer Ingelheim today announced a strategic ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...

Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in Stargardt disease patients MALVERN, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ocug ...

Consolidates all research activities across PureHealth’s Abu Dhabi hospitals, primary care clinics and advanced laboratories ...